<p>在过去三个月中，9 位分析师对 Hinge Health（纽约证券交易所代码：HNGE）进行了评估，提供了从看涨到看跌的多样化意见。</p>
<p>下表提供了他们最近评级的快照，展示了过去 30 天情绪的演变，并与前几个月进行了比较。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>在对 12 个月价格目标的评估中，分析师为 Hinge Health 揭示了见解，呈现出平均目标为 64.11 美元，最高估计为 71.00 美元，最低估计为 59.00 美元。当前平均价格目标较之前的 65.71 美元下降了 2.43%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769176819_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="价格目标图表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769176819_0.png"/></p>
<h2>解读分析师评级：深入分析</h2>
<p>通过最近的分析师行动，分析 Hinge Health 在金融专家眼中的认知。以下摘要呈现了关键分析师、他们的最新评估以及对评级和价格目标的调整。</p>
<table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gene Mannheimer</td>
<td>Freedom Capital Markets</td>
<td>宣布</td>
<td>买入</td>
<td>59.00 美元</td>
<td>-</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>下调</td>
<td>超配</td>
<td>60.00 美元</td>
<td>71.00 美元</td>
</tr>
<tr>
<td>Stan Berenshteyn</td>
<td>Wells Fargo</td>
<td>宣布</td>
<td>超配</td>
<td>68.00 美元</td>
<td>-</td>
</tr>
<tr>
<td>Scott Schoenhaus</td>
<td>Keybanc</td>
<td>下调</td>
<td>超配</td>
<td>70.00 美元</td>
<td>72.00 美元</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>维持</td>
<td>买入</td>
<td>59.00 美元</td>
<td>59.00 美元</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>下调</td>
<td>超配</td>
<td>60.00 美元</td>
<td>65.00 美元</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>上调</td>
<td>买入</td>
<td>65.00 美元</td>
<td>61.00 美元</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>上调</td>
<td>超配</td>
<td>65.00 美元</td>
<td>62.00 美元</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>上调</td>
<td>超配</td>
<td>71.00 美元</td>
<td>70.00 美元</td>
</tr>
</tbody>
</table>
<h3>关键见解：</h3>
<ul>
<li><strong>采取的行动：</strong> 针对动态市场条件和公司表现，分析师更新他们的建议。无论是 ‘维持’，‘上调’ 还是 ‘下调’ 他们的立场，都表明他们对 Hinge Health 近期发展的反应。这一见解提供了分析师对公司当前状态的看法快照。</li>
<li><strong>评级：</strong> 提供全面视角，分析师对股票进行定性评估，从 ‘跑赢大盘’ 到 ‘跑输大盘’。这些评级传达了对 Hinge Health 相对于更广泛市场表现的预期。</li>
<li><strong>价格目标：</strong> 分析师提供价格目标的见解，给出 Hinge Health 股票未来价值的估计。这一比较揭示了分析师预期随时间变化的趋势。</li>
</ul>
<p>将这些分析师评估与相关财务指标进行分析，可以提供 Hinge Health 市场地位的全面视角。保持信息灵通，并在我们的评级表的帮助下做出数据驱动的决策。</p>
<p>随时了解 Hinge Health 分析师评级。</p>
<h2>关于 Hinge Health</h2>
<p>Hinge Health Inc 是一个技术平台，旨在帮助个人治疗和预防关节和肌肉疼痛。通过结合人工智能驱动的运动跟踪技术，该公司的平台帮助会员解决肌肉骨骼（MSK）问题，提高会员的治疗效果，并支持客户的成本降低。该公司的客户是自保雇主。</p>
<h3>Hinge Health 的经济影响：分析</h3>
<p><strong>市值：</strong> 相较于行业平均水平，公司市值较小，面临独特挑战。</p>
<p><strong>收入增长：</strong> 在过去 3 个月中，Hinge Health 表现积极，截至 2025 年 9 月 30 日，收入增长率为 <strong>53.27%</strong>。这反映了公司营业收入的显著增加。与医疗保健行业的其他公司相比，该公司的增长率高于同行平均水平。</p>
<p><strong>净利润率：</strong> Hinge Health 的净利润率低于行业平均水平，表明在维持强劲盈利能力方面面临挑战。净利润率为 <strong>-1.2%</strong>，公司可能在有效成本管理方面遇到困难。</p>
<p><strong>股本回报率（ROE）：</strong> Hinge Health 的 ROE 低于行业标准，表明在有效利用股本方面存在困难。ROE 为 <strong>-0.97%</strong>，公司可能在为股东提供满意回报方面面临挑战。</p>
<p><strong>资产回报率（ROA）：</strong> Hinge Health 的 ROA 低于行业标准，表明在有效利用资产方面存在困难。ROA 为 <strong>-0.25%</strong>，公司可能在从其资产中提供满意回报方面面临挑战。</p>
<p><strong>债务管理：</strong> Hinge Health 的债务与股本比率低于行业规范，表明其财务结构良好，比例为 <strong>0.04</strong>。</p>
<h2>什么是分析师评级？</h2>
<p>分析师是银行和金融系统中的专家，通常为特定股票或特定行业报告。这些人研究公司财务报表，参加电话会议和会议，并与相关内部人士交谈，以确定股票的分析师评级。通常，分析师每季度会对每只股票进行评级。</p>
<p>除了他们的评估外，一些分析师还通过提供关键指标的预测（如收益、收入和增长估计）来扩展他们的见解。这些补充信息为交易者提供了进一步的指导。必须认识到，尽管他们是专家，分析师也是人，只能根据他们的信念提供预测。</p>
<p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>

标普医疗保健服务 ETF - SPDR

美国医药设备 ETF - iShares

HNGE

标普健康医疗设备 ETF - SPDR

美国医疗保健供应商 ETF - iShares

<p>分析师在过去三个月对 Hinge Health (NYSE:HNGE) 进行了评估，显示出看涨和看跌情绪的混合。12 个月的平均目标价格为 64.11 美元，较之前的 65.71 美元有所下降。最近的行动包括来自不同分析师的评级上调和下调，反映了市场状况。Hinge Health 的收入增长率为 53.27%，但面临净利润率为 -1.2% 的挑战，以及较低的股本回报率和资产回报率。公司的债务与股本比率为 0.04，表明其财务结构良好</p>

<p>Throughout the last three months, 9 analysts have evaluated Hinge Health (NYSE: HNGE), offering a diverse set of opinions from bullish to bearish.</p>
<div class="lb-trans"><p>在过去三个月中，9 位分析师对 Hinge Health（纽约证券交易所代码：HNGE）进行了评估，提供了从看涨到看跌的多样化意见。</p>
</div><p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<div class="lb-trans"><p>下表提供了他们最近评级的快照，展示了过去 30 天情绪的演变，并与前几个月进行了比较。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看涨</strong></th>
<th align="right"><strong>稍微看涨</strong></th>
<th align="right"><strong>无所谓</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>总评级</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>过去 30 天</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 个月前</strong></td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 个月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 个月前</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>In the assessment of 12-month price targets, analysts unveil insights for Hinge Health, presenting an average target of $64.11, a high estimate of $71.00, and a low estimate of $59.00. A 2.43% drop is evident in the current average compared to the previous average price target of $65.71.</p>
<div class="lb-trans"><p>在对 12 个月价格目标的评估中，分析师为 Hinge Health 揭示了见解，呈现出平均目标为 64.11 美元，最高估计为 71.00 美元，最低估计为 59.00 美元。当前平均价格目标较之前的 65.71 美元下降了 2.43%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769176819_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1769176819_0.png"/></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<div class="lb-trans"><h2>解读分析师评级：深入分析</h2>
</div><p>The perception of Hinge Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>通过最近的分析师行动，分析 Hinge Health 在金融专家眼中的认知。以下摘要呈现了关键分析师、他们的最新评估以及对评级和价格目标的调整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gene Mannheimer</td>
<td>Freedom Capital Markets</td>
<td>Announces</td>
<td>Buy</td>
<td>$59.00</td>
<td>-</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Stan Berenshteyn</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$68.00</td>
<td>-</td>
</tr>
<tr>
<td>Scott Schoenhaus</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$59.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析师</th>
<th>分析师公司</th>
<th>采取的行动</th>
<th>评级</th>
<th>当前价格目标</th>
<th>之前价格目标</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gene Mannheimer</td>
<td>Freedom Capital Markets</td>
<td>宣布</td>
<td>买入</td>
<td>59.00 美元</td>
<td>-</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>下调</td>
<td>超配</td>
<td>60.00 美元</td>
<td>71.00 美元</td>
</tr>
<tr>
<td>Stan Berenshteyn</td>
<td>Wells Fargo</td>
<td>宣布</td>
<td>超配</td>
<td>68.00 美元</td>
<td>-</td>
</tr>
<tr>
<td>Scott Schoenhaus</td>
<td>Keybanc</td>
<td>下调</td>
<td>超配</td>
<td>70.00 美元</td>
<td>72.00 美元</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>维持</td>
<td>买入</td>
<td>59.00 美元</td>
<td>59.00 美元</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>下调</td>
<td>超配</td>
<td>60.00 美元</td>
<td>65.00 美元</td>
</tr>
<tr>
<td>Richard Close</td>
<td>Canaccord Genuity</td>
<td>上调</td>
<td>买入</td>
<td>65.00 美元</td>
<td>61.00 美元</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>上调</td>
<td>超配</td>
<td>65.00 美元</td>
<td>62.00 美元</td>
</tr>
<tr>
<td>Jessica Tassan</td>
<td>Piper Sandler</td>
<td>上调</td>
<td>超配</td>
<td>71.00 美元</td>
<td>70.00 美元</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>关键见解：</h3>
</div><ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Hinge Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hinge Health compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Hinge Health's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>采取的行动：</strong> 针对动态市场条件和公司表现，分析师更新他们的建议。无论是 ‘维持’，‘上调’ 还是 ‘下调’ 他们的立场，都表明他们对 Hinge Health 近期发展的反应。这一见解提供了分析师对公司当前状态的看法快照。</li>
<li><strong>评级：</strong> 提供全面视角，分析师对股票进行定性评估，从 ‘跑赢大盘’ 到 ‘跑输大盘’。这些评级传达了对 Hinge Health 相对于更广泛市场表现的预期。</li>
<li><strong>价格目标：</strong> 分析师提供价格目标的见解，给出 Hinge Health 股票未来价值的估计。这一比较揭示了分析师预期随时间变化的趋势。</li>
</ul>
</div><p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Hinge Health's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<div class="lb-trans"><p>将这些分析师评估与相关财务指标进行分析，可以提供 Hinge Health 市场地位的全面视角。保持信息灵通，并在我们的评级表的帮助下做出数据驱动的决策。</p>
</div><p>Stay up to date on Hinge Health analyst ratings.</p>
<div class="lb-trans"><p>随时了解 Hinge Health 分析师评级。</p>
</div><h2>About Hinge Health</h2>
<div class="lb-trans"><h2>关于 Hinge Health</h2>
</div><p>Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.</p>
<div class="lb-trans"><p>Hinge Health Inc 是一个技术平台，旨在帮助个人治疗和预防关节和肌肉疼痛。通过结合人工智能驱动的运动跟踪技术，该公司的平台帮助会员解决肌肉骨骼（MSK）问题，提高会员的治疗效果，并支持客户的成本降低。该公司的客户是自保雇主。</p>
</div><h3>Hinge Health's Economic Impact: An Analysis</h3>
<div class="lb-trans"><h3>Hinge Health 的经济影响：分析</h3>
</div><p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<div class="lb-trans"><p><strong>市值：</strong> 相较于行业平均水平，公司市值较小，面临独特挑战。</p>
</div><p><strong>Revenue Growth:</strong> Over the 3M period, Hinge Health showcased positive performance, achieving a revenue growth rate of <strong>53.27%</strong> as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p>
<div class="lb-trans"><p><strong>收入增长：</strong> 在过去 3 个月中，Hinge Health 表现积极，截至 2025 年 9 月 30 日，收入增长率为 <strong>53.27%</strong>。这反映了公司营业收入的显著增加。与医疗保健行业的其他公司相比，该公司的增长率高于同行平均水平。</p>
</div><p><strong>Net Margin:</strong> Hinge Health's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-1.2%,</strong> the company may face hurdles in effective cost management.</p>
<div class="lb-trans"><p><strong>净利润率：</strong> Hinge Health 的净利润率低于行业平均水平，表明在维持强劲盈利能力方面面临挑战。净利润率为 <strong>-1.2%</strong>，公司可能在有效成本管理方面遇到困难。</p>
</div><p><strong>Return on Equity (ROE):</strong> Hinge Health's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-0.97%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<div class="lb-trans"><p><strong>股本回报率（ROE）：</strong> Hinge Health 的 ROE 低于行业标准，表明在有效利用股本方面存在困难。ROE 为 <strong>-0.97%</strong>，公司可能在为股东提供满意回报方面面临挑战。</p>
</div><p><strong>Return on Assets (ROA):</strong> Hinge Health's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-0.25%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<div class="lb-trans"><p><strong>资产回报率（ROA）：</strong> Hinge Health 的 ROA 低于行业标准，表明在有效利用资产方面存在困难。ROA 为 <strong>-0.25%</strong>，公司可能在从其资产中提供满意回报方面面临挑战。</p>
</div><p><strong>Debt Management:</strong> Hinge Health's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.04</strong>.</p>
<div class="lb-trans"><p><strong>债务管理：</strong> Hinge Health 的债务与股本比率低于行业规范，表明其财务结构良好，比例为 <strong>0.04</strong>。</p>
</div><h2>What Are Analyst Ratings?</h2>
<div class="lb-trans"><h2>什么是分析师评级？</h2>
</div><p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.</p>
<div class="lb-trans"><p>分析师是银行和金融系统中的专家，通常为特定股票或特定行业报告。这些人研究公司财务报表，参加电话会议和会议，并与相关内部人士交谈，以确定股票的分析师评级。通常，分析师每季度会对每只股票进行评级。</p>
</div><p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<div class="lb-trans"><p>除了他们的评估外，一些分析师还通过提供关键指标的预测（如收益、收入和增长估计）来扩展他们的见解。这些补充信息为交易者提供了进一步的指导。必须认识到，尽管他们是专家，分析师也是人，只能根据他们的信念提供预测。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自动内容引擎生成，并由编辑审核。</p>
</div>

分析师对 Hinge Health 未来发展的预期